KD On Other Exchanges
Symbol
Exchange
Mumbai

kabra drugs ltd (KD) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KABRA DRUGS LTD (KD)
\

Related News

No related news articles were found.

kabra drugs ltd (KD) Related Businessweek News

No Related Businessweek News Found

kabra drugs ltd (KD) Details

Kabra Drugs Limited does not have significant operations. Previously, the company was engaged in the manufacture and sale of drugs in India. The company was incorporated in 1989 and is based in Indore, India.

31 Employees
Last Reported Date: 08/23/18
Founded in 1989

kabra drugs ltd (KD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kabra drugs ltd
Kabra Drugs Limited, Board Meeting, May 30, 2010

Kabra Drugs Limited, Board Meeting, May 30, 2010. Agenda: To approve and take on record the Audited Financial Results of the Company for the quarter and year ended on 31st March 2019.

Kabra Drugs Limited Announces Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018

Kabra Drugs Limited announced earnings results for the third quarter and nine months ended December 31, 2018. For the third quarter, the company announced total comprehensive loss was INR 0.011 million compared to INR 0.960 million a year ago. Basic eps was INR 0 compared to basic loss per share of INR 0.02 a year ago. For the nine months, the company reported total comprehensive loss was INR 0.011 million compared to INR 0.960 million a year ago. Basic eps was INR 0 compared to basic loss per share of INR 0.18 a year ago.

Kabra Drugs Limited to Report Q3, 2019 Results on Feb 01, 2019

Kabra Drugs Limited announced that they will report Q3, 2019 results on Feb 01, 2019

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

KD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KD.
View Industry Companies
 

Industry Analysis

KD

Industry Average

Valuation KD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KABRA DRUGS LTD, please visit www.kabradrugsltd.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.